28 October 2020
Freemasons New Zealand have renewed their support of the Institute’s CAR T-cell programme, pledging a further $600,000 over the next three years.
![](/assets/Uploads/Images/General/37632-REC006__FocusFillWyIwLjAwIiwiMC4wMCIsMTAwLDQ1XQ.jpg)
The CAR T-cell team with Freemasons New Zealand
Freemasons New Zealand Grand Master Graham Wrigley says Freemasons New Zealand are proud to continue to support the Institute’s work because it is practical research that will have real outcomes that have the potential to improve the lives of all New Zealanders.
“Freemasons New Zealand donate extensively to medical research programmes like this CAR T-cell research because they are a promising and effective way that we can do something tangible to help New Zealanders. Our support is motivated by the guiding principles that underpin Freemasonry, particularly compassion and love of, and support for, humankind.”
Director of the Malaghan Institute professor Graham Le Gros says the financial partnership with the Freemasons provides a significant and vital boost to the Institute’s CAR T-cell research.
“As an independent research organisation and charity, the Malaghan Institute relies on support from the community and the generosity of organisations like Freemasons whose support, along with that of other organisations, will allow us to accelerate the availability of this ground-breaking treatment in New Zealand.”
Related articles
![Phase 2 clinical trial underway to confirm effectiveness and safety of NZ’s first CAR T-cell cancer therapy](/assets/Uploads/ENABLE-2-team__FocusFillWyIwLjAzIiwiLTAuMjgiLDY4MCw0NDVd.jpg)
Phase 2 clinical trial underway to confirm effectiveness and safety of NZ’s first CAR T-cell cancer therapy
23 July 2024
![CAR T-cells approved by EPA for phase 2 trial](/assets/Uploads/Images/General/cart__FocusFillWyIwLjAwIiwiMC4wMCIsNjgwLDQ0NV0.jpeg)
CAR T-cells approved by EPA for phase 2 trial
23 May 2024
![A revolution in cancer care is near; here’s what’s needed to make it happen](/assets/Uploads/Images/General/GLG-Labshot-1__FocusFillWyIwLjAwIiwiMC4wMCIsNjgwLDQ0NV0.jpg)
A revolution in cancer care is near; here’s what’s needed to make it happen
9 May 2024
![Significant milestone reached in first NZ CAR T-cell trial as preparations made for larger phase 2 registration trial](/assets/Uploads/Images/General/IMG_0446__FocusFillWyIwLjAwIiwiMC4wMCIsNjgwLDQ0NV0.jpg)
Significant milestone reached in first NZ CAR T-cell trial as preparations made for larger phase 2 registration trial
25 March 2024
![Freemasons New Zealand renews support for CAR T-cell therapy](/assets/Uploads/Images/General/Rachel-P-40316_CBM4705__FocusFillWyIwLjAwIiwiMC4wMCIsNjgwLDQ0NV0.jpg)
Freemasons New Zealand renews support for CAR T-cell therapy
10 November 2023
![RNZ: Engineering immune cells to kill cancer](/assets/Uploads/4L04KD5_cancer_collage_jpg__FocusFillWyIwLjAyIiwiLTAuMzIiLDY4MCw0NDVd.jpeg)
RNZ: Engineering immune cells to kill cancer
5 November 2023